ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 572,36
0,92%
Dow Jones
38 643,36
0,14%
DAX
18 076,32
0,31%
Brent Oil
83,155
1,25%
Bitcoin
65 276,29
-2,05%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. BioPharmX Corporation (BPMX)

  7. BioPharmX Corporation (BPMX) Actualités

BPMX

BioPharmX (BPMX)

BioPharmX Corporation
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:BPMX
DateHeureSourceTitreSymboleSociété
29/05/202012h04Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BPMXBioPharmX Corporation
28/05/202023h01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:BPMXBioPharmX Corporation
22/05/202023h17Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
19/05/202022h41GlobeNewswire Inc.Timber Pharmaceuticals Announces Investor Conference CallAMEX:BPMXBioPharmX Corporation
15/05/202022h05PR Newswire (US)BioPharmX Announces 1-for-12 Reverse Stock Split Merger Transaction Expected to Close on May 18, 2020AMEX:BPMXBioPharmX Corporation
13/05/202022h31Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
13/05/202022h05PR Newswire (US)BioPharmX Corporation Announces Approval of Merger by Stockholders at Special MeetingAMEX:BPMXBioPharmX Corporation
08/05/202015h00PR Newswire (US)BioPharmX Corporation Urges Stockholders to Vote Now on Proposed Merger with Timber PharmaceuticalsAMEX:BPMXBioPharmX Corporation
27/04/202022h20Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:BPMXBioPharmX Corporation
27/04/202022h05PR Newswire (US)BioPharmX Corporation Announces that its Special Stockholders' Meeting will now be held on Wednesday, May 13, 2020 at 10:00 A...AMEX:BPMXBioPharmX Corporation
06/04/202022h30PR Newswire (US)Timber Pharmaceuticals Announces Award of Second Tranche of FDA Orphan Products Clinical Trials GrantAMEX:BPMXBioPharmX Corporation
01/04/202022h18Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:BPMXBioPharmX Corporation
01/04/202012h01Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:BPMXBioPharmX Corporation
30/03/202012h17Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)AMEX:BPMXBioPharmX Corporation
25/03/202021h15PR Newswire (US)BioPharmX Receives Notice of Delisting from NYSE American But Stock will Remain TradingAMEX:BPMXBioPharmX Corporation
23/03/202021h24Edgar (US Regulatory)Annual Report (10-k)AMEX:BPMXBioPharmX Corporation
20/02/202012h03Edgar (US Regulatory)Securities Registration: Business Combination (s-4)AMEX:BPMXBioPharmX Corporation
13/02/202022h32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:BPMXBioPharmX Corporation
30/01/202022h30Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)AMEX:BPMXBioPharmX Corporation
30/01/202022h20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:BPMXBioPharmX Corporation
28/01/202022h30PR Newswire (US)BioPharmX And Timber Pharmaceuticals Announce Entry into Merger AgreementAMEX:BPMXBioPharmX Corporation
10/12/201922h51Edgar (US Regulatory)Quarterly Report (10-q)AMEX:BPMXBioPharmX Corporation
10/12/201922h05PR Newswire (US)BioPharmX Reports Fiscal Third Quarter 2020 Financial Results and Provides Corporate UpdateAMEX:BPMXBioPharmX Corporation
20/09/201922h05PR Newswire (US)BioPharmX Receives Notice of Compliance Deadline Extension from NYSE AmericanAMEX:BPMXBioPharmX Corporation
09/09/201914h15PR Newswire (US)BioPharmX Reports Fiscal Second Quarter 2020 Financial Results and Provides Corporate UpdateAMEX:BPMXBioPharmX Corporation
18/07/201923h42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BPMXBioPharmX Corporation
16/07/201922h15PR Newswire (US)BioPharmX Announces Steven M. Bosacki Joins the Company as Chief Operating OfficerAMEX:BPMXBioPharmX Corporation
25/06/201913h30PR Newswire (US)BioPharmX Announces Positive Topline Results from Phase 2b Trial of BPX-04 for Papulopustular RosaceaAMEX:BPMXBioPharmX Corporation
11/06/201922h10PR Newswire (US)BioPharmX Reports Fiscal First Quarter 2020 Financial ResultsAMEX:BPMXBioPharmX Corporation
22/05/201922h23Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:BPMXBioPharmX Corporation
 Showing the most relevant articles for your search:AMEX:BPMX

Dernières Valeurs Consultées

EU
ACA
Credit Agricole
NYSE
NKE
Nike
NASDAQ
AMZN
Amazon.com
EU
CAP
Capgemini
NASDAQ
AAPL
Apple
EU
BN
Danone
EU
BEL20
Bel 20
NYSE
JPM
JP Morgan Chase
EU
AF
Air FranceKLM
EU
MC
Lvmh Moet Hennessy Louis...
EU
CS
Axa
COIN
BTCUSD
Bitcoin
EU
GLE
Societe Generale
NYSE
KO
Coca Cola
EU
ORA
Orange
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés